PharmaBlock Sciences Nanjing Inc Class A (300725) — Net Asset Momentum
PharmaBlock Sciences Nanjing Inc Class A (300725) recorded a net asset momentum of 110.9% as of December 2025, with net assets of CN¥6.30 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See PharmaBlock Sciences Nanjing Inc Class A net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
PharmaBlock Sciences Nanjing Inc Class A Net Asset Momentum (2013–2025)
This chart tracks PharmaBlock Sciences Nanjing Inc Class A's year-over-year net asset growth across 13 annual reporting periods from 2013 to 2025. The most recent momentum reading is +110.9%, with net assets of CN¥6.30 Billion CNY as of December 2025. For live market cap and overall valuation, see PharmaBlock Sciences Nanjing Inc Class A market cap and net worth.
Annual Net Asset History for PharmaBlock Sciences Nanjing Inc Class A (2013–2025)
The table below shows the complete annual net asset history for PharmaBlock Sciences Nanjing Inc Class A from 2013 to 2025, covering 13 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check PharmaBlock Sciences Nanjing Inc Class A (300725) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥6.30 Billion | CN¥7.34 Billion | CN¥1.04 Billion | ▲ +110.9% |
| 2024 | CN¥2.99 Billion | CN¥4.94 Billion | CN¥1.95 Billion | ▲ +5.5% |
| 2023 | CN¥2.83 Billion | CN¥5.10 Billion | CN¥2.27 Billion | ▲ +6.6% |
| 2022 | CN¥2.66 Billion | CN¥4.86 Billion | CN¥2.20 Billion | ▲ +1.1% |
| 2021 | CN¥2.63 Billion | CN¥3.51 Billion | CN¥879.21 Million | ▲ +38.7% |
| 2020 | CN¥1.89 Billion | CN¥2.43 Billion | CN¥530.57 Million | ▲ +155.7% |
| 2019 | CN¥740.87 Million | CN¥1.03 Billion | CN¥288.27 Million | ▲ +23.5% |
| 2018 | CN¥599.73 Million | CN¥761.16 Million | CN¥161.43 Million | ▲ +19.1% |
| 2017 | CN¥503.59 Million | CN¥567.40 Million | CN¥63.80 Million | ▲ +98.1% |
| 2016 | CN¥254.15 Million | CN¥299.15 Million | CN¥45.00 Million | ▲ +73.4% |
| 2015 | CN¥146.56 Million | CN¥172.48 Million | CN¥25.92 Million | ▲ +68.1% |
| 2014 | CN¥87.18 Million | CN¥101.56 Million | CN¥14.38 Million | ▲ +24.3% |
| 2013 | CN¥70.16 Million | CN¥85.13 Million | CN¥14.97 Million | — |